196 related articles for article (PubMed ID: 37298777)
1.
El-Newary SA; Abd Elkarim AS; Abdelwahed NAM; Omer EA; Elgamal AM; ELsayed WM
Molecules; 2023 May; 28(11):. PubMed ID: 37298777
[No Abstract] [Full Text] [Related]
2. Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.
Martinez A; Regadera J; Jimenez E; Santos I; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Apr; 45(4):1008-13. PubMed ID: 11257009
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
[TBL] [Abstract][Full Text] [Related]
4. The Anti-Biofilm Efficacy of Caffeic Acid Phenethyl Ester (CAPE)
de Barros PP; Rossoni RD; Garcia MT; Kaminski VL; Loures FV; Fuchs BB; Mylonakis E; Junqueira JC
Front Cell Infect Microbiol; 2021; 11():700305. PubMed ID: 34408988
[No Abstract] [Full Text] [Related]
5. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
[TBL] [Abstract][Full Text] [Related]
6. The in vivo anti-Candida albicans activity of flavonoids.
Nguyen W; Grigori L; Just E; Santos C; Seleem D
J Oral Biosci; 2021 Jun; 63(2):120-128. PubMed ID: 33839266
[TBL] [Abstract][Full Text] [Related]
7. Riboflavin Targets the Cellular Metabolic and Ribosomal Pathways of Candida albicans
Lei J; Huang J; Xin C; Liu F; Zhang J; Xie Y; Mao Y; Chen W; Song Z
Microbiol Spectr; 2023 Feb; 11(1):e0380122. PubMed ID: 36625571
[TBL] [Abstract][Full Text] [Related]
8. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
9. Oral Administration of Human Polyvalent IgG by Mouthwash as an Adjunctive Treatment of Chronic Oral Candidiasis.
Pedraza-Sánchez S; Méndez-León JI; Gonzalez Y; Ventura-Ayala ML; Herrera MT; Lezana-Fernández JL; Bellanti JA; Torres M
Front Immunol; 2018; 9():2956. PubMed ID: 30627128
[No Abstract] [Full Text] [Related]
10. Use of photodynamic therapy and chitosan for inactivacion of Candida albicans in a murine model.
Fabio CA; Yolanda MB; Carmen GM; Francisco C; Antonio Julián B; Leonor PL; Jesús S
J Oral Pathol Med; 2016 Sep; 45(8):627-33. PubMed ID: 26991463
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of halocidin-derived peptide HG1 in a mouse model of Candida albicans oral infection.
Shin SH; Lee YS; Shin YP; Kim B; Kim MH; Chang HR; Jang WS; Lee IH
J Antimicrob Chemother; 2013 May; 68(5):1152-60. PubMed ID: 23302580
[TBL] [Abstract][Full Text] [Related]
12. Bioguided isolation, identification and activity evaluation of antifungal compounds from Acorus tatarinowii Schott.
Wang ZJ; Zhu YY; Yi X; Zhou ZS; He YJ; Zhou Y; Qi ZH; Jin DN; Zhao LX; Luo XD
J Ethnopharmacol; 2020 Oct; 261():113119. PubMed ID: 32679258
[TBL] [Abstract][Full Text] [Related]
13. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.
Melkoumov A; Goupil M; Louhichi F; Raymond M; de Repentigny L; Leclair G
J Antimicrob Chemother; 2013 Sep; 68(9):2099-105. PubMed ID: 23620465
[TBL] [Abstract][Full Text] [Related]
14. Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats.
Chami N; Chami F; Bennis S; Trouillas J; Remmal A
Braz J Infect Dis; 2004 Jun; 8(3):217-26. PubMed ID: 15476054
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Flavonoids in Combating Fluconazole Resistant Oral Candidiasis.
Srivastava D; Yadav A; Naqvi S; Awasthi H; Fatima Z
Curr Pharm Des; 2022; 28(21):1703-1713. PubMed ID: 35331090
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Nutraceuticals and Herbal Medicine on Candida albicans in Oral Candidiasis: A Comprehensive Review.
Gharibpour F; Shirban F; Bagherniya M; Nosouhian M; Sathyapalan T; Sahebkar A
Adv Exp Med Biol; 2021; 1308():225-248. PubMed ID: 33861447
[TBL] [Abstract][Full Text] [Related]
17. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
Zhang X; Li T; Chen X; Wang S; Liu Z
BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Antifungal Activity of Monolaurin against Candida albicans Biofilms.
Seleem D; Freitas-Blanco VS; Noguti J; Zancope BR; Pardi V; Murata RM
Biol Pharm Bull; 2018; 41(8):1299-1302. PubMed ID: 30068882
[TBL] [Abstract][Full Text] [Related]
19. Local, systemic, demographic, and health-related factors influencing pathogenic yeast spectrum and antifungal drug administration frequency in oral candidiasis: a retrospective study.
Hertel M; Schmidt-Westhausen AM; Strietzel FP
Clin Oral Investig; 2016 Sep; 20(7):1477-86. PubMed ID: 26481235
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
Hata K; Kimura J; Miki H; Toyosawa T; Moriyama M; Katsu K
Antimicrob Agents Chemother; 1996 Oct; 40(10):2243-7. PubMed ID: 8891122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
